59 units of tirzepatide (Zepbound) for weight loss 15 units tirzepatide Dosing question

10 mg Vial Protocol (2 mL = 5 mg/mL) - RECOMMENDED 20 mg Vial Protocol (4 mL = 5 mg/mL) Reconstitution: Add 4.0 mL bacteriostatic water 5 mg/mL concentration

Individual weight loss results may vary

Importantly, patients should seek immediate medical attention for warning signs such as: Severe, persistent abdominal pain (possible pancreatitis) Right upper quadrant pain, fever, or jaundice (possible gallbladder disease) Severe, persistent vomiting or diarrhea leading to dehydration Signs of allergic reaction including rash, swelling, or difficulty breathing Unusual neck mass, difficulty swallowing, hoarseness, or shortness of breath (thyroid concerns) Maintaining open communication ensures accurate diagnosis, appropriate monitoring, and optimal therapeutic outcomes while taking this medication

20% Average body weight loss in clinical trials 900k+ Patients trust Lemonaid Health 1x Once-weekly injection, fits into your routine Start Now 5-minute online assessment No obligation Clinician-led GLP-1 weight loss

The underlying weight loss guidance in our troubleshooting article for tirzepatide weight loss covers the full range of plateau-breaking strategies

One of the major trials of tirzepatide (the active ingredient in Zepbound and Mounjaro ) showed participants losing an average of 15%--21% of their body weight over a period of 72 weeks, with more weight loss in those taking the highest dose of the drug